Clearside Historical Balance Sheet

CLSD Stock

USD 0.41 0.19 31.67%

Trend analysis of Clearside Biomedical balance sheet accounts such as Other Current Liab of 2.4 M, Total Current Liabilities of 6.9 M or Property Plant And Equipment Net of 4 M provides information on Clearside Biomedical's total assets, liabilities, and equity, which is the actual value of Clearside Biomedical to its prevalent stockholders. By breaking down trends over time using Clearside Biomedical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Clearside Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Clearside Biomedical is a good buy for the upcoming year.

Clearside Biomedical Inventory

1.09

Build AI portfolio with Clearside Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.

About Clearside Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Clearside Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Clearside Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Clearside Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Clearside currently owns. An asset can also be divided into two categories, current and non-current.

Clearside Biomedical Balance Sheet Chart

At present, Clearside Biomedical's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 6.9 M, whereas Net Debt is forecasted to decline to (20.3 M).

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Clearside Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Clearside Biomedical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Clearside Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Clearside Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Clearside Biomedical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Clearside Biomedical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.At present, Clearside Biomedical's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 6.9 M, whereas Net Debt is forecasted to decline to (20.3 M).

	2022	2023	2024	2025 (projected)
Other Current Liabilities	3.8M	4.2M	1.6M	2.4M
Total Assets	51.3M	34.0M	25.1M	34.1M

Other Current Liab Total Assets

Clearside Biomedical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Accounts Payable	Common Stock Total Equity	Property Plant And Equipment Gross	Other Liab	Net Tangible Assets	Long Term Debt
Total Assets		0.38	0.52	0.61	0.22	-0.51	-0.42	0.76	0.23	0.01	0.03	0.99	-0.31	0.12	0.44	0.45	0.21	1.0	0.47	0.28	0.51	0.49	0.23	0.29	0.89	0.52
Other Current Liab	0.38		0.7	0.0	0.47	-0.05	-0.59	0.43	0.44	-0.16	0.12	0.33	-0.04	0.27	0.7	0.65	0.38	0.35	0.51	0.45	0.54	0.53	0.47	0.46	0.26	-0.02
Total Current Liabilities	0.52	0.7		0.24	0.3	-0.08	-0.55	0.33	0.24	-0.25	0.21	0.5	-0.31	0.05	0.8	0.6	0.21	0.51	0.47	0.28	0.76	0.49	0.23	0.12	0.49	0.28
Total Stockholder Equity	0.61	0.0	0.24		-0.46	-0.24	0.13	0.25	-0.48	-0.13	0.15	0.61	-0.12	-0.7	0.28	0.07	-0.65	0.64	-0.09	0.01	0.31	-0.05	-0.44	-0.29	0.71	0.37
Property Plant And Equipment Net	0.22	0.47	0.3	-0.46		-0.09	-0.85	0.42	0.93	-0.09	-0.35	0.17	0.24	0.74	0.31	0.68	0.77	0.18	0.85	0.39	0.1	0.83	0.99	0.85	0.24	-0.02
Net Debt	-0.51	-0.05	-0.08	-0.24	-0.09		0.35	-0.74	-0.22	-0.42	0.2	-0.49	0.05	-0.18	-0.18	-0.33	-0.2	-0.52	-0.44	0.45	0.2	-0.45	-0.16	-0.43	-0.4	0.06
Retained Earnings	-0.42	-0.59	-0.55	0.13	-0.85	0.35		-0.63	-0.82	0.03	0.39	-0.35	-0.19	-0.48	-0.64	-0.95	-0.57	-0.39	-0.98	-0.27	-0.24	-0.98	-0.86	-0.85	-0.47	-0.02
Cash	0.76	0.43	0.33	0.25	0.42	-0.74	-0.63		0.52	0.33	-0.28	0.72	-0.07	0.36	0.37	0.63	0.42	0.74	0.66	0.26	0.02	0.68	0.47	0.63	0.58	-0.03
Non Current Assets Total	0.23	0.44	0.24	-0.48	0.93	-0.22	-0.82	0.52		0.26	-0.32	0.19	0.14	0.79	0.27	0.64	0.81	0.19	0.81	0.36	0.04	0.79	0.93	0.83	0.18	-0.04
Non Currrent Assets Other	0.01	-0.16	-0.25	-0.13	-0.09	-0.42	0.03	0.33	0.26		-0.03	0.01	-0.22	0.21	-0.17	-0.07	0.18	0.01	-0.03	-0.07	-0.31	-0.02	-0.07	0.06	-0.17	-0.16
Other Assets	0.03	0.12	0.21	0.15	-0.35	0.2	0.39	-0.28	-0.32	-0.03		0.06	-0.71	-0.18	-0.04	-0.35	-0.15	0.03	-0.4	-0.02	0.33	-0.4	-0.39	-0.46	0.0	0.05
Cash And Short Term Investments	0.99	0.33	0.5	0.61	0.17	-0.49	-0.35	0.72	0.19	0.01	0.06		-0.34	0.11	0.37	0.37	0.2	0.99	0.39	0.27	0.52	0.41	0.18	0.21	0.86	0.56
Common Stock Shares Outstanding	-0.31	-0.04	-0.31	-0.12	0.24	0.05	-0.19	-0.07	0.14	-0.22	-0.71	-0.34		-0.11	-0.07	0.22	-0.16	-0.32	0.2	-0.08	-0.36	0.21	0.28	0.34	-0.13	-0.32
Non Current Liabilities Total	0.12	0.27	0.05	-0.7	0.74	-0.18	-0.48	0.36	0.79	0.21	-0.18	0.11	-0.11		-0.06	0.25	0.99	0.09	0.49	0.22	-0.01	0.45	0.74	0.62	-0.11	-0.01
Other Current Assets	0.44	0.7	0.8	0.28	0.31	-0.18	-0.64	0.37	0.27	-0.17	-0.04	0.37	-0.07	-0.06		0.74	0.07	0.42	0.56	0.18	0.54	0.58	0.29	0.33	0.49	0.2
Other Stockholder Equity	0.45	0.65	0.6	0.07	0.68	-0.33	-0.95	0.63	0.64	-0.07	-0.35	0.37	0.22	0.25	0.74		0.35	0.42	0.9	0.29	0.3	0.92	0.69	0.74	0.52	-0.02
Total Liab	0.21	0.38	0.21	-0.65	0.77	-0.2	-0.57	0.42	0.81	0.18	-0.15	0.2	-0.16	0.99	0.07	0.35		0.18	0.56	0.27	0.11	0.52	0.76	0.63	-0.02	0.04
Total Current Assets	1.0	0.35	0.51	0.64	0.18	-0.52	-0.39	0.74	0.19	0.01	0.03	0.99	-0.32	0.09	0.42	0.42	0.18		0.44	0.25	0.5	0.46	0.2	0.26	0.89	0.54
Common Stock	0.47	0.51	0.47	-0.09	0.85	-0.44	-0.98	0.66	0.81	-0.03	-0.4	0.39	0.2	0.49	0.56	0.9	0.56	0.44		0.2	0.16	1.0	0.88	0.89	0.54	0.02
Short Long Term Debt Total	0.28	0.45	0.28	0.01	0.39	0.45	-0.27	0.26	0.36	-0.07	-0.02	0.27	-0.08	0.22	0.18	0.29	0.27	0.25	0.2		0.31	0.21	0.34	0.18	0.2	0.06
Accounts Payable	0.51	0.54	0.76	0.31	0.1	0.2	-0.24	0.02	0.04	-0.31	0.33	0.52	-0.36	-0.01	0.54	0.3	0.11	0.5	0.16	0.31		0.16	0.04	-0.13	0.46	0.71
Common Stock Total Equity	0.49	0.53	0.49	-0.05	0.83	-0.45	-0.98	0.68	0.79	-0.02	-0.4	0.41	0.21	0.45	0.58	0.92	0.52	0.46	1.0	0.21	0.16		0.85	0.88	0.56	0.01
Property Plant And Equipment Gross	0.23	0.47	0.23	-0.44	0.99	-0.16	-0.86	0.47	0.93	-0.07	-0.39	0.18	0.28	0.74	0.29	0.69	0.76	0.2	0.88	0.34	0.04	0.85		0.91	0.25	-0.05
Other Liab	0.29	0.46	0.12	-0.29	0.85	-0.43	-0.85	0.63	0.83	0.06	-0.46	0.21	0.34	0.62	0.33	0.74	0.63	0.26	0.89	0.18	-0.13	0.88	0.91		0.31	-0.18
Net Tangible Assets	0.89	0.26	0.49	0.71	0.24	-0.4	-0.47	0.58	0.18	-0.17	0.0	0.86	-0.13	-0.11	0.49	0.52	-0.02	0.89	0.54	0.2	0.46	0.56	0.25	0.31		0.5
Long Term Debt	0.52	-0.02	0.28	0.37	-0.02	0.06	-0.02	-0.03	-0.04	-0.16	0.05	0.56	-0.32	-0.01	0.2	-0.02	0.04	0.54	0.02	0.06	0.71	0.01	-0.05	-0.18	0.5

Click cells to compare fundamentals

Clearside Biomedical Account Relationship Matchups

Clearside Biomedical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	19.3M	42.9M	51.3M	34.0M	25.1M	34.1M
Other Current Liab	1.2M	2.9M	3.8M	4.2M	1.6M	2.4M
Total Current Liabilities	9.9M	4.6M	5.8M	6.8M	4.8M	6.9M
Total Stockholder Equity	8.8M	38.0M	10.6M	(15.9M)	(38.9M)	(36.9M)
Property Plant And Equipment Net	944K	607K	1.9M	3.9M	3.8M	4.0M
Net Debt	(15.3M)	(29.8M)	(47.0M)	14.1M	(19.3M)	(20.3M)
Retained Earnings	(255.9M)	(255.5M)	(288.4M)	(320.9M)	(355.3M)	(337.5M)
Cash	17.3M	30.4M	48.3M	28.9M	20.0M	21.2M
Non Current Assets Total	1.2M	767K	3.0M	3.9M	3.9M	4.0M
Non Currrent Assets Other	260K	160K	1.1M	30K	27K	25.7K
Other Assets	260K	160K	30K	1.0	0.9	0.86
Cash And Short Term Investments	17.3M	30.4M	48.3M	28.9M	20.0M	30.5M
Common Stock Shares Outstanding	46.5M	59.9M	60.2M	61.8M	73.8M	44.0M
Non Current Liabilities Total	616K	288K	34.0M	43.1M	59.2M	62.1M
Other Current Assets	831K	1.7M	1.1M	1.0M	747K	1.0M
Other Stockholder Equity	264.6M	293.4M	299.0M	304.9M	316.3M	180.7M
Total Liab	10.6M	4.9M	40.7M	49.9M	64.0M	67.2M
Total Current Assets	18.1M	42.1M	48.3M	30.1M	21.3M	32.2M
Common Stock	52K	60K	61K	63K	77K	80.9K
Short Long Term Debt Total	2.0M	675K	1.3M	43.0M	703K	667.9K
Accounts Payable	2.0M	941K	1.1M	2.2M	1.5M	1.8M
Common Stock Total Equity	44K	52K	60K	61K	70.2K	73.7K
Liabilities And Stockholders Equity	19.3M	42.9M	51.3M	34.0M	25.1M	36.9M
Property Plant And Equipment Gross	944K	1.6M	2.7M	4.8M	5.0M	5.2M
Other Liab	605K	10.5M	4.6M	34.0M	39.1M	41.0M
Net Tangible Assets	11.2M	8.8M	38.0M	10.6M	12.2M	15.8M
Short Term Debt	1.7M	774K	698K	364K	750K	1.2M
Property Plant Equipment	1.2M	944K	238K	755K	868.3K	643.4K
Capital Surpluse	248.8M	264.6M	293.4M	299.0M	343.8M	222.9M
Retained Earnings Total Equity	(237.7M)	(255.9M)	(255.5M)	(288.4M)	(259.6M)	(272.6M)
Net Invested Capital	9.8M	38.0M	10.6M	(15.9M)	(38.9M)	(36.9M)
Net Working Capital	8.2M	37.5M	43.6M	23.3M	16.5M	27.7M
Capital Stock	52K	60K	61K	63K	77K	61.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:

How To Invest In Clearside

Details

Is Clearside Stock a good investment?

Details

What is Clearside Biomedical's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.41)

Revenue Per Share

0.05

Quarterly Revenue Growth

9.13

Return On Assets

(0.54)

Return On Equity

(13.10)

The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Clearside Historical Balance Sheet

Clearside Biomedical Inventory

1.09

About Clearside Balance Sheet Analysis

Clearside Biomedical Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Clearside Biomedical balance sheet Correlations

Clearside Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clearside Biomedical balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Common Stock Total Equity	+ 1.0	Common Stock
Cash And Short Term Investments	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Liab	+ 0.99	Non Current Liabilities Total

Common Stock Total Equity	- 0.98	Retained Earnings
Common Stock	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.95	Retained Earnings
Property Plant And Equipment Gross	- 0.86	Retained Earnings
Other Liab	- 0.85	Retained Earnings
Retained Earnings	- 0.85	Property Plant And Equipment Net